Paul F. Schellhammer

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Philip W. Kantoff, Celestia S. Higano, Neal D. Shore et al. · New England Journal of Medicine · 2010 · 5.5K citations · Full text

Medicine, Oncology, Urology +14

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

Mack Roach, Gerald E. Hanks, Howard D. Thames et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 2.7K citations

Medicine, Radiation Oncology, Urology +14

Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer

Eric J. Small, Paul F. Schellhammer, Celestia S. Higano et al. · Journal of Clinical Oncology · 2006 · 1.1K citations

Medicine, Oncology, Urology +16

Integrated data from 2 randomized, double‐blind, placebo‐controlled, phase 3 trials of active cellular immunotherapy with sipuleucel‐T in advanced prostate cancer

Celestia S. Higano, Paul F. Schellhammer, Eric J. Small et al. · Cancer · 2009 · 812 citations

Medicine, Immunology, Oncology +15

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

George L. Wright, Cara Haley, Mary Lou Beckett et al. · Urologic Oncology Seminars and Original Investigations · 1995 · 589 citations

Medicine, Pathology, Urology +12